Tag: otezla

October 17, 2017

Can-Fite Obtains Patent in Korea for Treatment of Psoriasis

Can-Fite BioPharma announced it obtained a patent from the Korean Intellectual Property Office for the Company’s lead drug candidate Piclidenoson...
October 20, 2016

Celgene Announces Oral OTEZLA® Receives Positive Nice Recommendation

Celgene announced today that adult patients in England and Wales with chronic plaque psoriasis will now have access to oral...
September 28, 2016

Celgene Announces Long-Term Safety Data for Oral OTEZLA®

Celgene International, a wholly owned subsidiary of Celgene Corporation, today announced that long-term safety findings from ongoing clinical trials.